[{"address1": "301 Edgewater Place", "address2": "Suite 100", "city": "Wakefield", "state": "MA", "zip": "01880", "country": "United States", "phone": "978 921 4125", "website": "https://www.ipharminc.com", "industry": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Innovation Pharmaceuticals Inc., a clinical stage biopharmaceutical company, develops small molecule therapies to treat inflammatory diseases, cancer, dermatology, and anti- infective. Its lead drug candidate is Brilacidin, a therapeutic for the treatment of oral mucositis, inflammatory bowel disease, acute bacterial skin and skin structure infection, and COVID-19. The company has a license agreement with Alfasigma S.p.A.; and collaborative research agreement with Fox Chase Chemical Diversity Center, Inc. The company was formerly known as Cellceutix Corporation and changed its name to Innovation Pharmaceuticals Inc. in June 2017. Innovation Pharmaceuticals Inc. was incorporated in 2005 and is headquartered in Wakefield, Massachusetts.", "fullTimeEmployees": 4, "companyOfficers": [{"maxAge": 1, "name": "Mr. Leo  Ehrlich CPA", "age": 65, "title": "Chairman, CEO, CFO, Principal Accounting Officer & Secretary", "yearBorn": 1958, "fiscalYear": 2023, "totalPay": 515850, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jane  Harness M.S., MP", "age": 55, "title": "Senior Vice President of Clinical Sciences & Portfolio Management", "yearBorn": 1968, "fiscalYear": 2023, "totalPay": 275000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jim  Boeheim", "title": "Business Advisor", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.011, "open": 0.0115, "dayLow": 0.0091, "dayHigh": 0.012, "regularMarketPreviousClose": 0.011, "regularMarketOpen": 0.0115, "regularMarketDayLow": 0.0091, "regularMarketDayHigh": 0.012, "beta": -0.283, "volume": 481261, "regularMarketVolume": 481261, "averageVolume": 844512, "averageVolume10days": 873473, "averageDailyVolume10Day": 873473, "marketCap": 6064671, "fiftyTwoWeekLow": 0.0007, "fiftyTwoWeekHigh": 0.03, "fiftyDayAverage": 0.0078584, "twoHundredDayAverage": 0.01140415, "currency": "USD", "enterpriseValue": 5895668, "floatShares": 466367785, "sharesOutstanding": 514014016, "heldPercentInsiders": 0.0953, "heldPercentInstitutions": 0.00017000001, "bookValue": 0.002, "priceToBook": 5.8499994, "lastFiscalYearEnd": 1688083200, "nextFiscalYearEnd": 1719705600, "mostRecentQuarter": 1696032000, "netIncomeToCommon": -2620000, "trailingEps": -0.01, "enterpriseToEbitda": -2.97, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "IPIX", "underlyingSymbol": "IPIX", "shortName": "INNOVATION PHARMACEUTICALS INC", "longName": "Innovation Pharmaceuticals Inc.", "firstTradeDateEpochUtc": 1178285400, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "31b56eb7-7135-39d9-b7fe-c276065fd99f", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.0117, "recommendationKey": "none", "totalCash": 864000, "totalCashPerShare": 0.002, "ebitda": -1985000, "totalDebt": 695000, "quickRatio": 0.171, "currentRatio": 0.186, "debtToEquity": 59.811, "returnOnAssets": -0.18424, "returnOnEquity": -1.14336, "freeCashflow": -986375, "operatingCashflow": -1992000, "financialCurrency": "USD", "trailingPegRatio": null}]